Lippincott ® NursingCenter ® Wolters Kluwer Logo

MRD Post-Remission Predicts Benefits of Transplant in NPM1-Mutated AML

Source:

Oncology Times

January 2024, Volume :46 Number 1 , page 37 - 37 [Free]

Go to article

Authors

  1. Fuerst , Mark L.

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

CE Resources

Nursing Resources

About NursingCenter

 

© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.06.00